Abstract 5960: Targeting CDK8: A translatable therapeutic approach for fusion-positive aRMSSusu Zhang, Kimberly Stegmaier, Clare F. Malone et al.|Cancer Research|2024Cited by 0
Abstract A022-PR005: CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-Driven Alveolar RhabdomyosarcomaSusu Zhang, Kimberly Stegmaier, Kathleen Engel et al.|Cancer Research|2025Cited by 0
Supplementary Appendix S1 from A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell CarcinomaJohn A. Ligon, John Glod, R. Taylor Sundby et al.|Unknown|2025Cited by 0
Supplementary Table S2 from A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell CarcinomaJohn A. Ligon, John Glod, Amanda Carbonell et al.|Unknown|2025Cited by 0